09/29/2023: 1:30 PM - 2:45 PM EDT
Parallel
Following the 2 talks, a panel comprised of experts from FDA and pharmaceutical industry will share their thoughts on how we embrace software and methodology innovation while ensuring quality. The panel will also address questions from the audience.
Open source
statistical software
software engineering
high-quality R packages
cross-company collaboration
regulatory considerations
Presenting Author(s)
Daniel Sabanes Bove, Roche
Eric Nantz, Eli Lilly and Company
Paul Schuette, FDA/CDER
Tae Hyun Jung, FDA